VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma. [electronic resource]
Producer: 20180116Description: 858-868 p. digitalISSN:- 2326-6074
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Neoplasm -- biosynthesis
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- CTLA-4 Antigen -- antagonists & inhibitors
- Cell Adhesion -- immunology
- Chemokine CXCL10 -- genetics
- Chemokines -- blood
- Cytokines -- blood
- Female
- Humans
- Intercellular Adhesion Molecule-1 -- metabolism
- Ipilimumab -- administration & dosage
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Male
- Melanoma -- drug therapy
- Middle Aged
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Tumor Cells, Cultured
- Tumor Microenvironment -- immunology
- Tumor Necrosis Factor-alpha -- immunology
- Up-Regulation -- immunology
- Vascular Cell Adhesion Molecule-1 -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.